The STCC Unified PD1/PDL1 Evaluation of Response (SUPER) study is a collaborative research effort led by the Singapore Translational Cancer Consortium (STCC) aimed at identifying biomarkers that ...
MARLBOROUGH, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (“Akoya”), The Spatial Biology Company ®, today announced a collaboration with the Singapore Translational Cancer ...
The STCC Unified PD1/PDL1 Evaluation of Response (SUPER) study is a multi-institutional study led by STCC with the goal of identifying predictors of PD1 immunotherapy response in an Asian real-world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results